VanEck Pharmaceutical ETF (PPH)
NasdaqGM: PPH
· Prix en temps réel · USD
113.20
+2.12 (1.91%)
À la clôture : Aug 18, 2026, 3:59 PM
VanEck Pharmaceutical ETF (PPH) ETF Price, Holdings & Analysis
1.91% (1D)
| Bid | n / A |
| Capitalisation boursière | n/a |
| AUM | 925.6M |
| NAV | 111.02 |
| Bêta | 0.4 |
| EPS (ttm) | n / A |
| Rapport PE (ttm) | 25.07 |
| Parts en circulation | 11.55M |
| Date de création | Dec 20, 2011 |
| Ask | n / A |
| Volume | 203,969 |
| Moy. Volume (20D) | 265,361 |
| Ouverture | 112.49 |
| Clôture précédente | 111.08 |
| Fourchette du jour | 112.49 - 113.45 |
| Intervalle de 52 semaines | 85.91 - 114.57 |
| Positions | n / A |
| Ratio de frais | 0.36% |
À propos de PPH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Classe d’actifs Equity
Symbole boursier PPH
Date de création Dec 20, 2011
Fournisseur Vaneck
Site web Page d’accueil du fonds
Échange NasdaqGM
10 principaux titres 72.44% des actifs
| Nom | Symbole | Poids |
|---|---|---|
| Eli Lilly And Co | LLY | 19.12% |
| Novartis Ag Adr | NVS | 10.54% |
| Merck & Co Inc | MRK | 9.76% |
| Novo Nordisk As Adr | NVO | 5.67% |
| Bristol-myers Squibb... | BMY | 4.94% |
| Mckesson Corp | MCK | 4.63% |
| Abbvie Inc | ABBV | 4.59% |
| Pfizer Inc | PFE | 4.58% |
| Gsk PLC Adr | GSK | 4.31% |
| Johnson & Johnson | JNJ | 4.30% |
Dividendes Rendement du dividende 1.92%
| Ex-dividende | Montant | Date de paiement |
|---|---|---|
| Jul 1, 2026 | $0.6250 | n / A |
| Apr 1, 2026 | $0.8440 | n / A |
| Dec 29, 2025 | $0.3110 | n / A |
| Oct 1, 2025 | $0.3930 | n / A |
| Jul 1, 2025 | $0.6070 | n / A |
1 semaine il y a · Zacks
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?Sector ETF report for PPH
Page 1 de 2